Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasm Metastasis × darolutamide × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8 Non-metastatic Castration-resistant Prostate Cancer 3 Urogenital Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Neoplasm Metastasis 1 Metastatic Hormone-sensitive Prostate Cancer 1 Fatigue 1 Depression 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Advanced Prostate Carcinoma 1

Interventions

Blood Specimen Collection 7 Radiosurgery 5 Drug Therapy 5 Therapeutics 4 Surveys and Questionnaires 4 Specimen Handling 4 Radiotherapy 4 Immunotherapy 4 exemestane 3 Hepatectomy 3 Hematologic Tests 3 Docetaxel 3 Data Collection 3 Biological Assay 3 Anastrozole 3 trastuzumab deruxtecan 2 palbociclib 2 enzalutamide 2 apalutamide 2 abiraterone 2 abemaciclib 2 Wearable Electronic Devices 2 Tamoxifen 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiofrequency Ablation 2 Prednisone 2 Nivolumab 2 Letrozole 2 Fulvestrant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06652607 2025-03-12

PSA-DEEP02

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡